Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
Quote | Milestone Pharmaceuticals Inc. (NYSE:MIST)
Last: | $ |
---|---|
Change Percent: | -3.27% |
Open: | $21.82 |
Close: | $21.02 |
High: | $21.8298 |
Low: | $20.30 |
Volume: | 395,676 |
Last Trade Date Time: | 02/12/2020 04:42:13 pm |
News | Milestone Pharmaceuticals Inc. (NYSE:MIST)
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
MONTREAL and CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will host Part I of its virtual investor educ...
Message Board Posts | Milestone Pharmaceuticals Inc. (NYSE:MIST)
Subject | By | Source | When |
---|---|---|---|
MIST So Sunday I said MIST should rise | MiamiGent | investorshub | 10/25/2022 3:56:06 PM |
No opps here, But thanks anyway. | fitzkarz | investorshub | 10/23/2020 4:06:10 PM |
Can u say opps. Take profits. Its pharma. | Harbor6460 | investorshub | 10/23/2020 3:19:52 PM |
* * $MIST Video Chart 07-24-2020 * * | ClayTrader | investorshub | 07/24/2020 8:22:03 PM |
fitzkarz Friday, 05/01/20 02:07:21 PM | fitzkarz | investorshub | 07/24/2020 7:07:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Milestone Pharmaceuticals Inc. Company Name:
MIST Stock Symbol:
NYSE Market:
Milestone Pharmaceuticals Inc. Website:
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
MONTREAL and CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will host Part I of its virtual investor educ...
MONTREAL and CHARLOTTE, N.C., May 31, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its management team will participate in the Jefferies Global Healthcare Conference being held in New York City, NY from June 4-6, 2024. ...